TIMELESS-BAZ2A Fusion FISH Probe
The TIMELESS-BAZ2A Fusion FISH Probe is used to confirm a fusion of the TIMELESS and BAZ2A genes. The fusion of the TIMELESS and BAZ2A genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TIMELESS-BAZ2A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TIMELESS-BAZ2A-20-AQAQ | 20 (40 μL) | 200 μL |
|
TIMELESS Gene Summary
The protein encoded by this gene is highly conserved and is involved in cell survival after damage or stress, increase in DNA polymerase epsilon activity, maintenance of telomere length, and epithelial cell morphogenesis. The encoded protein also plays a role in the circadian rhythm autoregulatory loop, interacting with the PERIOD genes (PER1, PER2, and PER3) and others to downregulate activation of PER1 by CLOCK/ARNTL. Changes in this gene or its expression may promote prostate cancer, lung cancer, breast cancer, and mental disorders. [provided by RefSeq, Feb 2014]
Gene Name: Timeless Circadian Regulator
Chromosome: CHR12: 56810156 -56843200
Locus: 12q13.3
BAZ2A Gene Summary
The Bromodomain Adjacent To Zinc Finger Domain 2A (BAZ2A) gene is located on chr12 :56989379-57030163 at 12q13.3.
Gene Name: Bromodomain Adjacent To Zinc Finger Domain 2A
Chromosome: CHR12: 56989379 -57030163
Locus: 12q13.3
Gene Diseases
The TIMELESS BAZ2A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|